{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:59:46Z","timestamp":1793721586058,"version":"4.6.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100015565","name":"Consorzio interuniversitario Biotecnologie","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015565","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015565","name":"Consorzio interuniversitario Biotecnologie","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015565","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UK Research and Innovation (MC_PC_20060) UK Coronavirus Immunology Consortium"},{"name":"UK Research and Innovation (MC_PC_20060) UK Coronavirus Immunology Consortium"},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["COV-LT2-0041"],"award-info":[{"award-number":["COV-LT2-0041"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PolyBio Research Foundation"},{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-024-00644-w","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T06:07:29Z","timestamp":1719295649000},"page":"1121-1136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19"],"prefix":"10.1038","volume":"4","author":[{"given":"Beatrice","family":"Dallan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Proietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"De Laurentis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Gallerani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ghisellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"Zurlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Volpato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Govoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Borghesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1947-2644","authenticated-orcid":false,"given":"Valentina","family":"Albanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5434-3963","authenticated-orcid":false,"given":"Victor","family":"Appay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bonnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Llewellyn-Lacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Pacifico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Grumiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Brandolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Semprini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Sambri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9856-2938","authenticated-orcid":false,"given":"Kristin","family":"Ladell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9707-8167","authenticated-orcid":false,"given":"Helen M.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-1967","authenticated-orcid":false,"given":"Paul A. H.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9416-2737","authenticated-orcid":false,"given":"David A.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"RIV Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Boni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Dall\u2019Olio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"De Laurentis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Fiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Fiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Govoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Romagnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Gavioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6327-5958","authenticated-orcid":false,"given":"Francesco","family":"Nicoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"key":"644_CR1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114583","volume":"385","author":"EG Levin","year":"2021","unstructured":"Levin, E. G. et al. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N. Engl. J. Med. 385, e84 (2021).","journal-title":"N. Engl. J. Med."},{"key":"644_CR2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","volume":"399","author":"DR Feikin","year":"2022","unstructured":"Feikin, D. R. et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet 399, 924\u2013944 (2022).","journal-title":"Lancet"},{"key":"644_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn4338","volume":"15","author":"SP Andeweg","year":"2023","unstructured":"Andeweg, S. P. et al. Elevated risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variants compared with Alpha variant in vaccinated individuals. Sci. Transl. Med. 15, eabn4338 (2023).","journal-title":"Sci. Transl. Med."},{"key":"644_CR4","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa2114255","volume":"385","author":"YM Bar-On","year":"2021","unstructured":"Bar-On, Y. M. et al. Protection of BNT162b2 vaccine booster against Covid-19 in Israel. N. Engl. J. Med. 385, 1393\u20131400 (2021).","journal-title":"N. Engl. J. Med."},{"key":"644_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41591-022-02138-x","volume":"29","author":"ST Tan","year":"2023","unstructured":"Tan, S. T. et al. Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave. Nat. Med. 29, 358\u2013365 (2023).","journal-title":"Nat. Med."},{"key":"644_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add3899","volume":"7","author":"Y Maringer","year":"2022","unstructured":"Maringer, Y. et al. Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination. Sci. Immunol. 7, eadd3899 (2022).","journal-title":"Sci. Immunol."},{"key":"644_CR7","doi-asserted-by":"publisher","first-page":"12295","DOI":"10.18632\/aging.203065","volume":"13","author":"F Nicoli","year":"2021","unstructured":"Nicoli, F., Paudel, D. & Solis-Soto, M. T. Old and new coronaviruses in the elderly. Aging 13, 12295\u201312296 (2021).","journal-title":"Aging"},{"key":"644_CR8","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s11357-020-00217-w","volume":"42","author":"F Nicoli","year":"2020","unstructured":"Nicoli, F. et al. Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity. Geroscience 42, 1015\u20131019 (2020).","journal-title":"Geroscience"},{"key":"644_CR9","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1016\/S2666-7568(22)00035-6","volume":"3","author":"L Arregoc\u00e9s-Castillo","year":"2022","unstructured":"Arregoc\u00e9s-Castillo, L. et al. Effectiveness of COVID-19 vaccines in older adults in Colombia: a retrospective, population-based study of the ESPERANZA cohort. Lancet Healthy Longev. 3, e242\u2013e252 (2022).","journal-title":"Lancet Healthy Longev."},{"key":"644_CR10","doi-asserted-by":"publisher","first-page":"6664","DOI":"10.1016\/j.vaccine.2022.09.080","volume":"40","author":"CE Van Ewijk","year":"2022","unstructured":"Van Ewijk, C. E., Hazelhorst, E. I., Hahne, S. J. M. & Knol, M. J. COVID-19 outbreak in an elderly care home: very low vaccine effectiveness and late impact of booster vaccination campaign. Vaccine 40, 6664\u20136669 (2022).","journal-title":"Vaccine"},{"key":"644_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2045857","volume":"18","author":"E Nanishi","year":"2022","unstructured":"Nanishi, E., Levy, O. & Ozonoff, A. Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review. Hum. Vaccin. Immunother. 18, 2045857 (2022).","journal-title":"Hum. Vaccin. Immunother."},{"key":"644_CR12","doi-asserted-by":"crossref","unstructured":"Baj\u010di, M. P. et al. COVID-19 breakthrough infections among patients aged \u226565 years in Serbia: morbidity and mortality overview. Vaccines 10, 1818 (2022).","DOI":"10.3390\/vaccines10111818"},{"key":"644_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhip.2022.100307","volume":"4","author":"MI Ventura","year":"2022","unstructured":"Ventura, M. I. et al. Vaccine breakthrough infections with SARS-CoV-2: why older adults need booster vaccinations. Public Health Pract. 4, 100307 (2022).","journal-title":"Public Health Pract."},{"key":"644_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10522-014-9514-3","volume":"16","author":"J Hazeldine","year":"2015","unstructured":"Hazeldine, J. & Lord, J. M. Innate immunesenescence: underlying mechanisms and clinical relevance. Biogerontology 16, 187\u2013201 (2015).","journal-title":"Biogerontology"},{"key":"644_CR15","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3389\/fimmu.2020.01748","volume":"11","author":"LL Cunha","year":"2020","unstructured":"Cunha, L. L., Perazzio, S. F., Azzi, J., Cravedi, P. & Riella, L. V. Remodeling of the immune response with aging: immunosenescence and its potential impact on COVID-19 immune response. Front. Immunol. 11, 1748 (2020).","journal-title":"Front. Immunol."},{"key":"644_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.693054","volume":"12","author":"E Gallerani","year":"2021","unstructured":"Gallerani, E. et al. Impaired priming of SARS-CoV-2-specific naive CD8+ T cells in older subjects. Front. Immunol. 12, 693054 (2021).","journal-title":"Front. Immunol."},{"key":"644_CR17","doi-asserted-by":"crossref","unstructured":"Proietto, D. et al. Ageing curtails the diversity and functionality of nascent CD8+ T cell responses against SARS-CoV-2. Vaccines 11, 154 (2023).","DOI":"10.3390\/vaccines11010154"},{"key":"644_CR18","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4049\/jimmunol.2100194","volume":"208","author":"F Nicoli","year":"2022","unstructured":"Nicoli, F. et al. Altered basal lipid metabolism underlies the functional impairment of naive CD8+ T cells in elderly humans. J. Immunol. 208, 562\u2013570 (2022).","journal-title":"J. Immunol."},{"key":"644_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s43587-023-00379-0","volume":"3","author":"C Xiao","year":"2023","unstructured":"Xiao, C. et al. Insufficient epitope-specific T cell clones are responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in older adults. Nat. Aging 3, 418\u2013435 (2023).","journal-title":"Nat. Aging"},{"key":"644_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103852","volume":"76","author":"F Nicoli","year":"2022","unstructured":"Nicoli, F. et al. Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years old. EBioMedicine 76, 103852 (2022).","journal-title":"EBioMedicine"},{"key":"644_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.coviro.2021.09.017","volume":"51","author":"H Zhang","year":"2021","unstructured":"Zhang, H., Weyand, C. M., Goronzy, J. J. & Gustafson, C. E. Understanding T cell aging to improve anti-viral immunity. Curr. Opin. Virol. 51, 127\u2013133 (2021).","journal-title":"Curr. Opin. Virol."},{"key":"644_CR22","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jaci.2020.03.017","volume":"145","author":"CE Gustafson","year":"2020","unstructured":"Gustafson, C. E., Kim, C., Weyand, C. M. & Goronzy, J. J. Influence of immune aging on vaccine responses. J. Allergy Clin. Immunol. 145, 1309\u20131321 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"644_CR23","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41591-022-01721-6","volume":"28","author":"J Wei","year":"2022","unstructured":"Wei, J. et al. Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines. Nat. Med. 28, 1072\u20131082 (2022).","journal-title":"Nat. Med."},{"key":"644_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","volume":"596","author":"DA Collier","year":"2021","unstructured":"Collier, D. A. et al. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature 596, 417\u2013422 (2021).","journal-title":"Nature"},{"key":"644_CR25","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.1016\/S2666-7568(22)00118-0","volume":"3","author":"G Tut","year":"2022","unstructured":"Tut, G. et al. Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study. Lancet Healthy Longev. 3, e461\u2013e469 (2022).","journal-title":"Lancet Healthy Longev."},{"key":"644_CR26","doi-asserted-by":"publisher","first-page":"e27753","DOI":"10.1371\/journal.pone.0027753","volume":"6","author":"AH Roukens","year":"2011","unstructured":"Roukens, A. H. et al. Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study. PLoS ONE 6, e27753 (2011).","journal-title":"PLoS ONE"},{"key":"644_CR27","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3389\/fimmu.2018.01035","volume":"9","author":"B Weinberger","year":"2018","unstructured":"Weinberger, B. et al. Impaired immune response to primary but not to booster vaccination against hepatitis B in older adults. Front. Immunol. 9, 1035 (2018).","journal-title":"Front. Immunol."},{"key":"644_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.7326\/M17-3439","volume":"168","author":"DK Kim","year":"2018","unstructured":"Kim, D. K. et al. Recommended immunization schedule for adults aged 19 years or older, United States, 2018. Ann. Intern. Med. 168, 210\u2013220 (2018).","journal-title":"Ann. Intern. Med."},{"key":"644_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12979-017-0107-2","volume":"15","author":"B Weinberger","year":"2018","unstructured":"Weinberger, B. Vaccines for the elderly: current use and future challenges. Immun. Ageing 15, 3 (2018).","journal-title":"Immun. Ageing"},{"key":"644_CR30","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/jcmm.17186","volume":"26","author":"M Chivu-Economescu","year":"2022","unstructured":"Chivu-Economescu, M. et al. Kinetics and persistence of cellular and humoral immune responses to SARS-CoV-2 vaccine in healthcare workers with or without prior COVID-19. J. Cell. Mol. Med. 26, 1293\u20131305 (2022).","journal-title":"J. Cell. Mol. Med."},{"key":"644_CR31","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/s41564-022-01163-3","volume":"7","author":"J Newman","year":"2022","unstructured":"Newman, J. et al. Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2. Nat. Microbiol. 7, 1180\u20131188 (2022).","journal-title":"Nat. Microbiol."},{"key":"644_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/infdis\/jiac421","volume":"227","author":"M Agallou","year":"2023","unstructured":"Agallou, M. et al. Antibody and T-cell subsets analysis unveils an immune profile heterogeneity mediating long-term responses in individuals vaccinated against SARS-CoV-2. J. Infect. Dis. 227, 353\u2013363 (2023).","journal-title":"J. Infect. Dis."},{"key":"644_CR33","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41590-022-01313-z","volume":"23","author":"N Brasu","year":"2022","unstructured":"Brasu, N. et al. Memory CD8+ T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination. Nat. Immunol. 23, 1445\u20131456 (2022).","journal-title":"Nat. Immunol."},{"key":"644_CR34","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27, 1205\u20131211 (2021).","journal-title":"Nat. Med."},{"key":"644_CR35","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S0140-6736(21)02183-8","volume":"398","author":"SY Tartof","year":"2021","unstructured":"Tartof, S. Y. et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet 398, 1407\u20131416 (2021).","journal-title":"Lancet"},{"key":"644_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108728","volume":"34","author":"AT Tan","year":"2021","unstructured":"Tan, A. T. et al. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients. Cell Rep. 34, 108728 (2021).","journal-title":"Cell Rep."},{"key":"644_CR37","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","volume":"185","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell 185, 2434\u20132451 (2022).","journal-title":"Cell"},{"key":"644_CR38","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/s41591-021-01464-w","volume":"27","author":"T Schmidt","year":"2021","unstructured":"Schmidt, T. et al. Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19\/mRNA vaccination. Nat. Med. 27, 1530\u20131535 (2021).","journal-title":"Nat. Med."},{"key":"644_CR39","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S2213-2600(21)00357-X","volume":"9","author":"D Hillus","year":"2021","unstructured":"Hillus, D. et al. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study. Lancet Respir. Med. 9, 1255\u20131265 (2021).","journal-title":"Lancet Respir. Med."},{"key":"644_CR40","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/S0140-6736(21)02717-3","volume":"398","author":"APS Munro","year":"2021","unstructured":"Munro, A. P. S. et al. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Lancet 398, 2258\u20132276 (2021).","journal-title":"Lancet"},{"key":"644_CR41","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1056\/NEJMc2115596","volume":"385","author":"AY Collier","year":"2021","unstructured":"Collier, A. Y. et al. Differential kinetics of immune responses elicited by Covid-19 vaccines. N. Engl. J. Med. 385, 2010\u20132012 (2021).","journal-title":"N. Engl. J. Med."},{"key":"644_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl5344","volume":"6","author":"G Guerrera","year":"2021","unstructured":"Guerrera, G. et al. BNT162b2 vaccination induces durable SARS-CoV-2-specific T cells with a stem cell memory phenotype. Sci. Immunol. 6, eabl5344 (2021).","journal-title":"Sci. Immunol."},{"key":"644_CR43","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41591-023-02219-5","volume":"29","author":"JJ Lau","year":"2023","unstructured":"Lau, J. J. et al. Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population. Nat. Med. 29, 348\u2013357 (2023).","journal-title":"Nat. Med."},{"key":"644_CR44","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41590-022-01212-3","volume":"23","author":"Y Lustig","year":"2022","unstructured":"Lustig, Y. et al. Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose. Nat. Immunol. 23, 940\u2013946 (2022).","journal-title":"Nat. Immunol."},{"key":"644_CR45","doi-asserted-by":"publisher","first-page":"7811","DOI":"10.2147\/IDR.S390351","volume":"15","author":"B Wolszczak Biedrzycka","year":"2022","unstructured":"Wolszczak Biedrzycka, B., Bie\u0144kowska, A., Smoli\u0144ska-Fijo\u0142ek, E., Biedrzycki, G. & Dorf, J. The influence of two priming doses of different anti-COVID-19 vaccines on the production of anti-SARS-CoV-2 antibodies after the administration of the Pfizer\/BioNTech booster. Infect. Drug Resist. 15, 7811\u20137821 (2022).","journal-title":"Infect. Drug Resist."},{"key":"644_CR46","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMoa2116414","volume":"386","author":"RL Atmar","year":"2022","unstructured":"Atmar, R. L. et al. Homologous and heterologous Covid-19 booster vaccinations. N. Engl. J. Med. 386, 1046\u20131057 (2022).","journal-title":"N. Engl. J. Med."},{"key":"644_CR47","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.immuni.2023.02.017","volume":"56","author":"M Koutsakos","year":"2023","unstructured":"Koutsakos, M. et al. SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses. Immunity 56, 879\u2013892 (2023).","journal-title":"Immunity"},{"key":"644_CR48","doi-asserted-by":"publisher","first-page":"E257","DOI":"10.1002\/ajh.26185","volume":"96","author":"E Terpos","year":"2021","unstructured":"Terpos, E. et al. Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine. Am. J. Hematol. 96, E257\u2013E259 (2021).","journal-title":"Am. J. Hematol."},{"key":"644_CR49","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1093\/cid\/ciab381","volume":"73","author":"L M\u00fcller","year":"2021","unstructured":"M\u00fcller, L. et al. Age-dependent immune response to the Biontech\/Pfizer BNT162b2 coronavirus disease 2019 vaccination. Clin. Infect. Dis. 73, 2065\u20132072 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"644_CR50","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s43587-022-00292-y","volume":"2","author":"M\u00c1 Palacios-Pedrero","year":"2022","unstructured":"Palacios-Pedrero, M. \u00c1. et al. Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults. Nat. Aging 2, 896\u2013905 (2022).","journal-title":"Nat. Aging"},{"key":"644_CR51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s43587-022-00328-3","volume":"3","author":"G Tut","year":"2023","unstructured":"Tut, G. et al. Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes. Nat. Aging 3, 93\u2013104 (2023).","journal-title":"Nat. Aging"},{"key":"644_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100739","volume":"3","author":"H Parry","year":"2022","unstructured":"Parry, H. et al. Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people. Cell Rep. Med. 3, 100739 (2022).","journal-title":"Cell Rep. Med."},{"key":"644_CR53","doi-asserted-by":"crossref","unstructured":"Wang, Z. et al. Memory B cell development elicited by mRNA booster vaccinations in the elderly. J. Exp. Med. 220, e20230668 (2023).","DOI":"10.1084\/jem.20230668"},{"key":"644_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.778679","volume":"12","author":"J Demaret","year":"2021","unstructured":"Demaret, J. et al. Impaired functional T-cell response to SARS-CoV-2 after two doses of BNT162b2 mRNA vaccine in older people. Front. Immunol. 12, 778679 (2021).","journal-title":"Front. Immunol."},{"key":"644_CR55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s43587-022-00343-4","volume":"3","author":"N Jo","year":"2023","unstructured":"Jo, N. et al. Impaired CD4+ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination. Nat. Aging 3, 82\u201392 (2023).","journal-title":"Nat. Aging"},{"key":"644_CR56","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.4049\/jimmunol.2200369","volume":"209","author":"JA Breznik","year":"2022","unstructured":"Breznik, J. A. et al. Cytomegalovirus seropositivity in older adults changes the T cell repertoire but does not prevent antibody or cellular responses to SARS-CoV-2 vaccination. J. Immunol. 209, 1892\u20131905 (2022).","journal-title":"J. Immunol."},{"key":"644_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104294","volume":"85","author":"E Vogel","year":"2022","unstructured":"Vogel, E. et al. Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2. EBioMedicine 85, 104294 (2022).","journal-title":"EBioMedicine"},{"key":"644_CR58","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1056\/NEJMoa2116063","volume":"386","author":"ES Rosenberg","year":"2022","unstructured":"Rosenberg, E. S. et al. Covid-19 vaccine effectiveness in New York State. N. Engl. J. Med. 386, 116\u2013127 (2022).","journal-title":"N. Engl. J. Med."},{"key":"644_CR59","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1084\/jem.20051357","volume":"202","author":"DA Price","year":"2005","unstructured":"Price, D. A. et al. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J. Exp. Med. 202, 1349\u20131361 (2005).","journal-title":"J. Exp. Med."},{"key":"644_CR60","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/QAD.0000000000001734","volume":"32","author":"F Nicoli","year":"2018","unstructured":"Nicoli, F. et al. The HIV-1 Tat protein affects human CD4+ T-cell programing and activation, and favors the differentiation of naive CD4+ T cells. AIDS 32, 575\u2013581 (2018).","journal-title":"AIDS"}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00644-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00644-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00644-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T10:04:01Z","timestamp":1724061841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00644-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":60,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["644"],"URL":"https:\/\/doi.org\/10.1038\/s43587-024-00644-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3101473\/v1","asserted-by":"object"}]},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"assertion":[{"value":"30 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}